Cancure Limited
Records under this name other than the patents Cancure Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Cancure Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE47,300 | Mitochondrially delivered anti-cancer compounds Lapsed on the fee record Ended Dec 3, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 3, 2025 | From the USPTO record |
| US 8,410,056 | Pro-oxidant anti-cancer compounds Lapsed on the fee record Ended Apr 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 2, 2025 | From the USPTO record |
| US 10,953,045 | Agents and compositions for eliciting an immune response Lapsed on the fee record Ended Mar 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 23, 2025 | From the USPTO record |
| US 8,598,145 | Mitochondrially delivered anti-cancer compounds Surrendered on reissue Surrendered on reissue Mar 19, 2019 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Mar 19, 2019 | From the USPTO record |